Related Experiment Videos
Can extended dosing intervals reduce drug costs while maintaining patient care?
1St. James Hospital and Health Centers, Chicago Heights, IL.
Hospital Formulary
|July 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Effects of vedolizumab, adalimumab and infliximab on biliary inflammation in individuals with primary sclerosing cholangitis and inflammatory bowel disease.
Alimentary pharmacology & therapeutics·2018
Postoperative outcomes in vedolizumab-treated Crohn's disease patients undergoing major abdominal operations.
Alimentary pharmacology & therapeutics·2017
The utility of a non-verbal prospective memory measure as a sensitive marker for early-stage Alzheimer's disease in Hong Kong.
International psychogeriatrics·2014
Outcomes measurement across the continuum of care.
Medical interface·1997
A model for developing longitudinal health records.
Medical interface·1996
Safety, efficacy, and lipid profile of doxazosin at a VA medical center.
Hospital formulary·1995
A team approach to adverse drug reaction surveillance: success at a tertiary care hospital.
Hospital formulary·1995
The changing relationship between health care professionals and the pharmaceutical industry.
Hospital formulary·1995
Antibiotic therapeutic interchange program: six years of experience.
Hospital formulary·1995
How a CQI program improved aminoglycoside use in a community hospital.
Hospital formulary·1995
Automation in pharmacy: two institutions' experiences with novel distribution systems.
Hospital formulary·1995
Effectiveness and Safety of Spesolimab in Adolescents and Adults with Generalized Pustular Psoriasis.
Pragmatic and observational research·2026
Preclinical Evaluation of Anti-Acne Topical Creams Containing Psorospermum Febrifugum Stem Bark Extract: Lipase Inhibition, Sebum Regulation, and Dermal Safety.
Clinical, cosmetic and investigational dermatology·2026
Impact of Hydrogel Spacer on Radiation Proctitis After Prostate Cancer Radiation Therapy: A Large-Scale Claims Database Analysis.
Advances in radiation oncology·2026
Discovery of a Potent and Selective KRAS G12D Degrader based on PROTAC Degradation.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026